Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. The company’s lead compound ZEN-3694, which is in Phase 2 clinical trial for the treatment of metastatic castration... Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. The company’s lead compound ZEN-3694, which is in Phase 2 clinical trial for the treatment of metastatic castration resistant prostate cancer in collaboration with Astellas and Newsoara, as well as advanced or metastatic triple-negative breast cancer in collaboration with Pfizer. It has a research and development collaboration agreement with the National Cancer Institute. The company was formerly known as Zenith Epigenetics Corp. and changed its name to Zenith Capital Corp. in August 2016. Zenith Capital Corp. was incorporated in 2013 and is headquartered in Calgary, Canada. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.1 | 0.1 | 0.1 | 3350 | 0.1 | CS |
| 4 | 0.05 | 100 | 0.05 | 0.1 | 0.0016 | 3237 | 0.05401122 | CS |
| 12 | 0.05 | 100 | 0.05 | 0.15 | 0.0004 | 6343 | 0.05760726 | CS |
| 26 | -0.02 | -16.6666666667 | 0.12 | 0.19 | 0.0003 | 12742 | 0.1039655 | CS |
| 52 | 0 | 0 | 0.1 | 0.19 | 0.0001 | 10401 | 0.09119975 | CS |
| 156 | -0.07 | -41.1764705882 | 0.17 | 0.25 | 1.0E-6 | 13480 | 0.10380575 | CS |
| 260 | -0.1725 | -63.3027522936 | 0.2725 | 0.45 | 1.0E-6 | 13225 | 0.13428572 | CS |
otcstardmn
13分前
barnstormer
52分前
Steady_T
1時間前
newflow
1時間前
FrostyIsland3
1時間前
bwrbad
2時間前
newflow
2時間前
barnstormer
2時間前
FrostyIsland3
2時間前
Steady_T
2時間前
ron_66271
2時間前
barnstormer
2時間前
newflow
2時間前
KRISGO
2時間前
Kjv
2時間前
newflow
2時間前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。